Literature DB >> 5266577

A comparative study of two live measles vaccines in Iran.

H Mirchamsy, A Shafyi, Y Bassali, S Bahrami, F Nazari.   

Abstract

The results of immunization of 523 children from 9 months to over 5 years of age with two attenuated measles vaccines, ;Denken' and ;Biken', are described. The clinical reactions following vaccination with both vaccines were mild, but Denken vaccine produced more rashes than the Biken vaccine. The serological conversion was satisfactory for both vaccines but a higher titre of neutralizing and haemagglutination-inhibiting antibodies was found in children immunized with Denken vaccine. The incidence of severe reactions or complications was negligible in this trial. The immunity to diphtheria or tetanus was not altered by vaccination with live measles vaccine.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5266577      PMCID: PMC2130774          DOI: 10.1017/s0022172400028552

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  11 in total

1.  COMPARISON OF THE HEMAGGLUTINATION INHIBITION TEST FOR MEASLES WITH SEROLOGICAL TESTS AND ITS APPLICATION TO A FIELD TRIAL.

Authors:  N KUNITA; T KITAWAKI; S FUNAHASHI; K TOYOSHIMA
Journal:  Biken J       Date:  1963-07

2.  Live measles-virus vaccine: clinical trial of vaccine prepared from a variant of the Sugiyama strain adapted to bovine kidney cells.

Authors:  M MATUMOTO; M MUTAI; Y SABURI; R FUJII; M MINAMITANI; K NAKAMURA
Journal:  Jpn J Exp Med       Date:  1962-10

3.  Attenuated measles-virus strain in the U.S.S.R.

Authors:  L L FADEEVA; M A DADASHYAN; D D LEBEDEV; V M ZHDANOV
Journal:  Am J Dis Child       Date:  1962-03

4.  Clinical and immunological response to live tissue culture vaccine against measles.

Authors:  A A SMORODINTSEV; L M BOICHUK; E S SHIKINA; T B BATANOVA; L V BYSTRYAKOVA; T V PERADZE
Journal:  Acta Virol       Date:  1960-07       Impact factor: 1.162

5.  Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.

Authors:  J F ENDERS; S L KATZ; M V MILOVANOVIC; A HOLLOWAY
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

6.  Role of interferon in replication of virulent and attenuated strains of measles virus.

Authors:  H Mirchamsy; F Rapp
Journal:  J Gen Virol       Date:  1969-06       Impact factor: 3.891

7.  Comparative study of live attenuated and further attenuated measles vaccines in rural areas of Iran.

Authors:  K Naficy; S Saidi; R Nategh; A Mostatab; E Akbarshahy
Journal:  Arch Gesamte Virusforsch       Date:  1967

8.  The use of dried whole blood absorbed on filter-paper for the evaluation of diphtheria and tetanus antitoxins in mass surveys.

Authors:  H Mirchamsy; F Nazari; C Stellman; H Esterabady
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

9.  Studies on the combined use of killed and live measles vaccines. 3. Conditions for the "take" of live vaccine.

Authors:  S Ueda; H Hosai; Y Minekawa; Y Okuno
Journal:  Biken J       Date:  1966-06

10.  Effects of Tween 80 and freon 113 on measles virus.

Authors:  W Parisius; H G Macmorine
Journal:  Appl Microbiol       Date:  1969-03
View more
  3 in total

1.  Differentiation of smallpox and camelpox viruses in cultures of human and monkey cells.

Authors:  D Baxby
Journal:  J Hyg (Lond)       Date:  1974-04

2.  Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran.

Authors:  H Mirchamsy; A Shafyi; M R Rafyi; S Bahrami; P Nazari; S Fatemie
Journal:  J Hyg (Lond)       Date:  1974-04

3.  Evaluation of live attenuated measles vaccines prepared in human diploid cells for reimmunization.

Authors:  H Mirchamsy; A Shafyi; P Nazari; M P Ashtiani; A Sassani
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.